Literature DB >> 20079595

Percutaneous coronary intervention, diabetes mellitus, and death.

Harold L Dauerman.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20079595     DOI： 10.1016/j.jacc.2009.09.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  6 in total

1.  Efficacy of one- vs. two-stent implantation for coronary bifurcation lesions in diabetic patients utilizing AIR2 as an endpoint.

Authors:  Zhizhong Liu; Guozhen Jin; Yuzhen Qi; Shoujie Shan; Junjie Zhang; Fei Ye; Nailiang Tian; Jiupei Chen; Shaoliang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  [Prevalence of undetected diabetes mellitus in invasive and interventional cardiology. Silent diabetes in the catheterization laboratory].

Authors:  R Dörr; J Stumpf; S G Spitzer; B Krosse; D Tschöpe; T Lohmann; O Schnell
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

3.  Coronary artery disease: revascularization strategies for patients with CAD and diabetes.

Authors:  G Robert Myers; William S Weintraub
Journal:  Nat Rev Cardiol       Date:  2010-07       Impact factor: 32.419

4.  [Bypass surgery versus percutaneous coronary intervention in patients with diabetes mellitus].

Authors:  Rolf Dörr
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

5.  Increased coronary intervention rate among diabetic patients with poor glycaemic control: a cross-sectional study.

Authors:  Süha Çetin; Mehmet Akif Öztürk; Nadir Barındık; Ersin İmren; Yüksel Peker
Journal:  Bosn J Basic Med Sci       Date:  2014-02       Impact factor: 3.363

6.  Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.

Authors:  Seyed Ebrahim Kassaian; Hamidreza Goodarzynejad; Mohammad Ali Boroumand; Mojtaba Salarifar; Farzad Masoudkabir; Mohammad Reza Mohajeri-Tehrani; Hamidreza Pourhoseini; Saeed Sadeghian; Narges Ramezanpour; Mohammad Alidoosti; Elham Hakki; Soheil Saadat; Ebrahim Nematipour
Journal:  Cardiovasc Diabetol       Date:  2012-07-17       Impact factor: 9.951
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.